BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7556412)

  • 1. Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist.
    Gitter BD; Waters DC; Threlkeld PG; Lovelace AM; Matsumoto K; Bruns RF
    Eur J Pharmacol; 1995 May; 289(3):439-46. PubMed ID: 7556412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
    Suman-Chauhan N; Grimson P; Guard S; Madden Z; Chung FZ; Watling K; Pinnock R; Woodruff G
    Eur J Pharmacol; 1994 Sep; 269(1):65-72. PubMed ID: 7530207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
    Strigas J; Burcher E
    Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
    Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
    Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
    Goldhill J; Angel I
    Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
    Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
    Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
    Robineau P; Lonchampt M; Kucharczyk N; Krause JE; Regoli D; Fauchere JL; Prost JF; Canet E
    Eur J Pharmacol; 1995 Dec; 294(2-3):677-84. PubMed ID: 8750733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
    Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
    Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.